Literature DB >> 10733236

Partial CFTR genotyping and characterisation of cystic fibrosis patients with myocardial fibrosis and necrosis.

J Zebrak1, B Skuza, A Pogorzelski, R Ligarska, E Kopytko, J Pawlik, E Rutkiewicz, M Witt.   

Abstract

Myocardial necrosis and fibrosis is a rare complication of cystic fibrosis (CF) causing sudden and unexpected death in infancy due to cardiac arrest. Characteristic morphological lesions are recognisable postmortem. The 18 CF patients with this complication had varied clinical features including mild pulmonary involvement, early onset severe pancreatic insufficiency, and profound electrocardiogram (ECG) changes. In this group of patients, 5 were deltaF508 homozygotes, 1 was deltaF508/ N1303K and 1 was a deltaF508/M compound heterozygote. A pair of affected siblings (deltaF508 homozygotes) were fully concordant for myocardial involvement and for the general course of the disease. The co-existence of a genetic predisposition to myocardial lesions resulting most probably from severe cystic fibrosis transmembrane (CFTR) genotypes (such as deltaF508/deltaF508, deltaF508/N1303K) and deficiency of certain trophic factors necessary for metabolism of the myocardium, are postulated to cause myocardial complications in CF leading to circulatory failure and early death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10733236     DOI: 10.1034/j.1399-0004.2000.570108.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  3 in total

1.  Cardiomyocytes with disrupted CFTR function require CaMKII and Ca(2+)-activated Cl(-) channel activity to maintain contraction rate.

Authors:  Zachary M Sellers; Vania De Arcangelis; Yang Xiang; Philip M Best
Journal:  J Physiol       Date:  2010-05-04       Impact factor: 5.182

2.  Left ventricular and aortic dysfunction in cystic fibrosis mice.

Authors:  Zachary M Sellers; Attila Kovacs; Carla J Weinheimer; Philip M Best
Journal:  J Cyst Fibros       Date:  2012-12-24       Impact factor: 5.482

3.  Cardiac involvement in cystic fibrosis evaluated using cardiopulmonary magnetic resonance.

Authors:  Jakub Lagan; Josephine H Naish; Joshua Bradley; Christien Fortune; Charlie Palmer; David Clark; Erik B Schelbert; Matthias Schmitt; Rowland Bright-Thomas; Christopher A Miller
Journal:  Int J Cardiovasc Imaging       Date:  2022-01-07       Impact factor: 2.357

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.